London Calling 2025 - Speakers
Speakers
Check out the line up of speakers at London Calling 2025.
Oxford Nanopore Technologies
Dr. Luca Mazzarella
- Job title
- Institution
- European Institute of Oncology, Italy
- Biography
Dr. Luca Mazzerella is a physician scientist who specializes in medical oncology in Milan, Italy. He obtained his PhD in molecular biology at Imperial College London. Currently, Luca runs the laboratory of Translational Oncology at the European Institute of Oncology (IEO) in Milan, where he focuses on cancer genomics and bioinformatics across multiple cancers. As a clinician, he has worked for several years in phase-1 trials, and recently moved into gastrointestinal oncology.
- Recent publications
Di Chiaro, P. et al. Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve invasion in pancreatic cancer. Cancer Cell 42(4):662–681 E10 (2024). DOI: https://doi.org/10.1016/j.ccell.2024.02.017
Magi, A. et al. High-resolution nanopore methylome-maps reveal random hyper-methylation at CpG-poor regions as driver of chemoresistance in leukemias. Comm Biol. A6(1):382 (2023). DOI: 10.1038/s42003- 023-04756-8. Erratum in: Commun Biol. 6(1):455 (2023).
Favalli, V. et al. Machine learning-based reclassification of germline variants of unknown significance: the RENOVO algorithm. Am J Hum Gen. 108(4):682–695 (2021). DOI: 10.1016/j.ajhg.2021.03.010
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.
